SM Dobbs
Impact in
-
- Balance, Gait, and Falls Prevention
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 3
- Botulinum Toxin and Related Neurological Disorders 2
-
- Heart Failure Treatment and Management 2
- Co-authors
- P. W. Nicholson (11 shared papers)RJ Dobbs (11 shared papers)M. Denham (3 shared papers)Clive Weller (7 shared papers)J. P. Royston (2 shared papers)P Clark (3 shared papers)André Charlett (5 shared papers)G. E. Mawer (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (14 papers)Helicobacter (1 paper)Clinical Science (1 paper)
- Partner nations
- United KingdomUnited StatesPoland
In The Last Decade
SM Dobbs
16 papers receiving 271 citations
Peers
Comparison fields: 5 of 65
- Physical Therapy, Sports Therapy and Rehabilitation 49
- Neurology 145
- Geriatrics and Gerontology 24
- Family Practice 10
- Applied Microbiology and Biotechnology 8
Countries citing papers authored by SM Dobbs
This map shows the geographic impact of SM Dobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SM Dobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SM Dobbs more than expected).
Fields of papers citing papers by SM Dobbs
This network shows the impact of papers produced by SM Dobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SM Dobbs. The network helps show where SM Dobbs may publish in the future.
Co-authors
The 20 scholars most cited alongside SM Dobbs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 46 | |
| 2 | 1987 | 41 | |
| 3 | 1988 | 35 | |
| 4 | 1987 | 33 | |
| 5 | 1990 | 31 | |
| 6 | 1976 | 30 | |
| 7 | 1993 | 23 | |
| 8 | 1991 | 16 | |
| 9 | 1980 | 13 | |
| 10 | 1992 | 7 | |
| 11 | 1990 | 7 | |
| 12 | 1977 | 5 | |
| 13 | 1991 | 3 | |
| 14 | Clinical significance of Helicobacter suis in idiopathic Parkinsonism | 2013 | 1 |
| 15 | 2001 | 1 | |
| 16 | 1976 | 1 |
About SM Dobbs
SM Dobbs is a scholar working on Neurology, Cardiology and Cardiovascular Medicine, Surgery, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology, having authored 16 papers that have together received 293 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Heart Failure Treatment and Management (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Pharmaceutical studies and practices (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Physical Therapy, Sports Therapy and Rehabilitation (49 citations), Neurology (145 citations), Geriatrics and Gerontology (24 citations), Family Practice (10 citations) and Applied Microbiology and Biotechnology (8 citations). SM Dobbs has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include P. W. Nicholson, RJ Dobbs, M. Denham, Clive Weller, J. P. Royston, P Clark, André Charlett, G. E. Mawer, SB Lucas and R. Cheung. Their work appears in journals such as British Journal of Clinical Pharmacology, Helicobacter and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.